Virtual Communities as an Organizational Mechanism for Embedding Knowledge in Drug Discovery: The Case of Chemical Biology Platform

Journal of Business Chemistry, Vol. 1, No. 2, 2004

11 Pages Posted: 22 Jul 2005

Abstract

In this paper, we document the lessons from the development of chemical biology platform in a major pharmaceutical company, and the outcomes of the early phases of this experiment. Altough the concept of chemical biology is not new, its evolution and deployment in the drug development process is relatively new. The present experiment thus has to deal with both the scientific novelty of chemical biology, and organizational challenge of embedding it in the ongoing process of drug development. The notion of virtual communities or platforms overlaid on the traditional matrix of drug development served to introduce the approach, with some remarkable outcomes.

Suggested Citation

Narayanan, V. K. and Douglas, Frank L. and Schirlin, Daniel and Wess, Gunther and Geising, Dennis, Virtual Communities as an Organizational Mechanism for Embedding Knowledge in Drug Discovery: The Case of Chemical Biology Platform. Journal of Business Chemistry, Vol. 1, No. 2, 2004. Available at SSRN: https://ssrn.com/abstract=757665

V. K. Narayanan (Contact Author)

Drexel University - LeBow College of Business ( email )

3141 Chestnut Street
Philadelphia, PA 19104
United States
215-895-6763 (Phone)

Frank L. Douglas

Ewing Marion Kauffman Foundation ( email )

4801 Rockhill Road
Kansas City, MO 64110-2046
United States
8169321204 (Phone)

Daniel Schirlin

Aventis Pharma

Kommunikation Deutschland
Königsteiner Straße 10
65812 Bad Soden a. Ts.
Germany

Gunther Wess

Aventis Pharma

Kommunikation Deutschland
Königsteiner Straße 10
65812 Bad Soden a. Ts.
Germany

Dennis Geising

Aventis Pharma

Kommunikation Deutschland
Königsteiner Straße 10
65812 Bad Soden a. Ts.
Germany

Register to save articles to
your library

Register

Paper statistics

Downloads
81
Abstract Views
1,166
rank
303,176
PlumX Metrics